Education
About Us
Working with TipRanks
Follow Us
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.17M | $ 18.14M | $ 39.02M | $ 10.99M | $ 6.91M |
| Gross Profit | $ 6.17M | $ 18.14M | $ 39.02M | $ 10.99M | $ -40.57M |
| Operating Income | $ -76.32M | $ -78.10M | $ -65.46M | $ -73.52M | $ -57.81M |
| EBITDA | $ -68.40M | $ -70.99M | $ -61.86M | $ -71.64M | $ -57.76M |
| Net Income | $ -69.92M | $ -72.85M | $ -69.46M | $ -76.25M | $ -63.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 122.62M | $ 126.00M | $ 146.91M | $ 155.32M | $ 123.27M |
| Total Assets | $ 131.71M | $ 144.40M | $ 195.42M | $ 204.49M | $ 137.08M |
| Total Debt | $ 1.29M | $ 8.72M | $ 12.55M | $ 18.91M | $ 22.54M |
| Net Debt | $ -35.04M | $ -17.56M | $ -18.22M | $ -90.37M | $ -29.71M |
| Total Liabilities | $ 34.34M | $ 38.38M | $ 58.57M | $ 35.05M | $ 35.11M |
| Stockholders' Equity | $ 97.37M | $ 106.02M | $ 136.85M | $ 169.44M | $ 101.97M |
| Cash Flow | |||||
| Free Cash Flow | $ -65.03M | $ -86.94M | $ -35.87M | $ -68.34M | $ -51.67M |
| Operating Cash Flow | $ -64.85M | $ -85.94M | $ -35.36M | $ -67.53M | $ -51.44M |
| Investing Cash Flow | $ 22.95M | $ 50.77M | $ -74.94M | $ -12.68M | $ -14.91M |
| Financing Cash Flow | $ 52.00M | $ 30.65M | $ 31.81M | $ 137.24M | $ 86.75M |
Arbutus Biopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.